FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2023

FAIR VALUE MEASUREMENTS

Schedule of financial assets measured at fair value on a recurring basis

The following fair value hierarchy table presents information about the Company’s financial assets measured at fair value on a recurring basis and indicates the fair value hierarchy of the inputs the Company utilized to determine such fair value (in thousands):

	September 30, 2023
	Quoted Prices in		Significant
	Active Markets		Other		Significant
	for Identical		Observable		Unobservable
	Items		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Money market funds	$	63,671	$	—	$	—	$	63,671
Equity securities		803		—		—		803
Other investments		—		—		2,000		2,000
Total assets	$	64,474	$	—	$	2,000	$	66,474

	December 31, 2022
	Quoted Prices in		Significant
	Active Markets		Other		Significant
	for Identical		Observable		Unobservable
	Items		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Money market funds	$	51,274	$	—	$	—	$	51,274
Commercial paper		—		39,781		—		39,781
Corporate bonds		—		28,814		—		28,814
U.S. Treasury securities		—		19,818		—		19,818
Government bonds		—		14,744		—		14,744
Asset-backed securities		—		3,998		—		3,998
Equity securities		1,088		—		—		1,088
Other investments		—		—		2,000		2,000
Total assets	$	52,362	$	107,155	$	2,000	$	161,517
Liabilities:
Contingent consideration	$	—	$	—	$	2,587	$	2,587
Total liabilities	$	—	$	—	$	2,587	$	2,587

Schedule of Level 3 assets measured at fair value

	Nine Months Ended September 30,
	2023		2022
Balance at beginning of period	$	2,000	$	6,750
Changes in fair value		—		(745)
Disposals		—		(3,155)
Balance at end of period	$	2,000	$	2,850

Schedule of Level 3 liabilities measured at fair value

The following table presents information about the Company’s movement in Level 3 liabilities measured at fair value (in thousands):

	Nine Months Ended September 30,
	2023		2022
Balance at beginning of period	$	2,587	$	5,654
Payment of contingent consideration liability		(2,390)		(1,500)
Sale of Aerosint		(197)		—
Changes in fair value		—		(254)
Balance at end of period	$	—	$	3,900